Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Vir Biotechnology (NASDAQ:VIR) Stock Bumped Down to "Strong Sell" by Zacks Research - Markets Daily
Vir Biotechnology (NASDAQ:VIR) Cut to "Strong Sell" at Zacks Research
How Upcoming SOLSTICE Phase 2 HDV Data Could Shape Vir Biotechnology's (VIR) Investment Narrative
VIR Maintains by HC Wainwright & Co. -- Price Target Raised to $
Vir Biotechnology (NASDAQ:VIR) Given New $22.00 Price Target at HC Wainwright
Vir Biotechnology to Present Expanded Phase 2 SOLSTICE Results for Elebsiran and Tobevibart in Hepatitis Delta at AASLD's The Liver Meeting® 2026 | Morningstar
Vir Biotechnology (VIR) Could Be 48% Undervalued Following Its CFO Appointment
Vir Biotechnology, Inc. (NASDAQ:VIR) Stock Rated "Moderate Buy" by Sell-Side Brokerages
Bank of America Corp DE Acquires 1,142,539 Shares of Vir Biotechnology, Inc. $VIR
Reviewing Tango Therapeutics (NASDAQ:TNGX) and Vir Biotechnology (NASDAQ:VIR) - Stock Observer
VirBiotechnology News
GE Vernova Stock Forecast & Analysis: Will Data-Centre Power and Grid Investment Fuel the Next Rally?
Samsung Electronics Stock Price Forecast 2026–2027: Can Record Q3 Profit Extend the AI Rally?
GBP/USD Forecast: Can Sterling Hold 1.32 as Fed Rate-Hike Bets Rise?
AUD to USD Forecast 2026–2030: Can the Aussie Reclaim 0.71 After the RBA’s Fourth Rate Hike?
Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?
Latest news
Show more
Delta Earnings Preview: Can Strong Travel Demand Offset Oil Above $104?
Oil Prices Surge as Brent Tops $104 on Iran Tensions and Hurricane Isaias
US Consumer Sentiment Preview: Will Rising Inflation Expectations Keep the Fed Hawkish?
Tesla Stock Slips Despite $500 Price Target as FSD Delays and Spending Stay in Focus
EUR/USD Holds Near a 17-Month Low as France’s Debt Crisis Weighs on the Euro
AI Stocks Tumble as OpenAI Revenue Run Rate Comes In $20 Billion Below Earlier Reports
